Search - tctmd.com

Displaying 41 - 60 of 126

Sort: Relevancy | Date

News Conference News ACC 2022

In Vaccine Era, Deaths Drop Sharply in STEMI Patients With COVID-19

Caitlin E. Cox

April 04, 2022

Seasonal, but No Year-round, Protection With Flu Shots in HF: IVVE

News Conference News ACC 2022

Seasonal, but No Year-round Help for HF With Flu Shots: IVVE

Yael L. Maxwell

April 03, 2022

SODIUM-HF: No Impact of Dietary Salt Restriction on Death or Hospitalization

News Conference News ACC 2022

SODIUM-HF: No Impact of Tighter Dietary Salt Restriction on Death or Hospitalization

L.A. McKeown

April 02, 2022

News Conference News ACC 2022

What’s Going to Be Hot at ACC 2022, In Person or Virtual

Shelley Wood

March 28, 2022

News Conference News ACC 2022

Can a Smartphone App Use Voice Patterns to Predict CAD Events?

Caitlin E. Cox

March 24, 2022

News Conference News ACC 2021

FFR Doesn’t Beat Angio for Complete Revasc in STEMI: FLOWER-MI

Caitlin E. Cox

May 25, 2021

News Conference News ACC 2021

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Michael O'Riordan

May 25, 2021

News Conference News ACC 2021

Complete Revascularization Analysis of ISCHEMIA Opens ‘Pandora’s Box’

Michael O'Riordan

May 18, 2021

News Conference News ACC 2021

RAFT-AF: No Benefit of AF Ablation for Heart Failure Patients

Todd Neale

May 17, 2021

News Conference News ACC 2021

ACTION: Full-Dose Rivaroxaban Doesn’t Help in Hospitalized COVID-19

Todd Neale

May 17, 2021

Presentation ACC 2021

Effect of a Hospital and Post-discharge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction

Presenter: Adam DeVore

May 17, 2021

News Conference News ACC 2021

Clopidogrel, Not Aspirin, for Post-DAPT Monotherapy After PCI: HOST-EXAM

L.A. McKeown

May 16, 2021

News Conference News ACC 2021

REHAB-HF: Tailored Cardiac Rehab Promotes Physical Function After Hospital Stay

Caitlin E. Cox

May 16, 2021

News Conference News ACC 2021

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

Shelley Wood

May 16, 2021

News Conference News ACC 2021

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

Yael L. Maxwell

May 16, 2021

News Conference News ACC 2021

PARADISE-MI: ARNI Doesn’t Surpass ACE Inhibitor After Acute MI

L.A. McKeown

May 15, 2021

News Conference News ACC 2021

Emergent CABG in Acute MI: Survival Better Despite Increasingly Risky Patients

Caitlin E. Cox

May 15, 2021

News Conference News ACC 2021

High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE

Michael O'Riordan

May 15, 2021

News Conference News ACC 2021

Occluding the LAA During Surgery Lowers Stroke Risk: LAAOS III

Todd Neale

May 15, 2021

News Conference News ACC 2021

For Younger MI Survivors, Stress Boosts Adverse Outcomes

Caitlin E. Cox

May 13, 2021

Advertisement

In Vaccine Era, Deaths Drop Sharply in STEMI Patients With COVID-19

Seasonal, but No Year-round Help for HF With Flu Shots: IVVE

SODIUM-HF: No Impact of Tighter Dietary Salt Restriction on Death or Hospitalization

What’s Going to Be Hot at ACC 2022, In Person or Virtual

Can a Smartphone App Use Voice Patterns to Predict CAD Events?

FFR Doesn’t Beat Angio for Complete Revasc in STEMI: FLOWER-MI

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Complete Revascularization Analysis of ISCHEMIA Opens ‘Pandora’s Box’

RAFT-AF: No Benefit of AF Ablation for Heart Failure Patients

ACTION: Full-Dose Rivaroxaban Doesn’t Help in Hospitalized COVID-19

Effect of a Hospital and Post-discharge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction

Clopidogrel, Not Aspirin, for Post-DAPT Monotherapy After PCI: HOST-EXAM

REHAB-HF: Tailored Cardiac Rehab Promotes Physical Function After Hospital Stay

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

Sacubitril/Valsartan Lowers Triglycerides in HFpEF: PARAGON-HF

PARADISE-MI: ARNI Doesn’t Surpass ACE Inhibitor After Acute MI

Emergent CABG in Acute MI: Survival Better Despite Increasingly Risky Patients

High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE

Occluding the LAA During Surgery Lowers Stroke Risk: LAAOS III

For Younger MI Survivors, Stress Boosts Adverse Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content